The effect of consumption of barberry fruit powder in type 2 diabetic patients

The effect of consumption of barberry fruit powder on glycemic indices , lipid profile and Visfatin in type 2 diabetic patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180811040758N1

Enrollment

Registered

2018-10-06

Start date

2018-10-23

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: The intervention group received 1 gram of powdered barberry dried fruit (2 capsules of 500mg) per serving for 2 months (1 capsule plus lunch and 1 capsule with dinn

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: People with type 2 diabetes are diagnosed

Exclusion criteria

Exclusion criteria: Pregnancy Lactation History of heart disease History of heart failure in the last 3 months heart attack Acute and chronic hepatic disease, except fatty liver Impaired kidney function Hyperthyroidism and hypothyroidism Use of NSAIDs Insulin treatment Taking antidepressants

Design outcomes

Primary

Measure	Time frame
Fasting blood suger. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;HbA1c. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.	—

Measure

Time frame

Fasting blood suger. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;HbA1c. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: Beginning of the intervention and 60 days after the intervention. Method of measurement: Measure with laboratory kit on blood sample.

—

Secondary

Measure	Time frame
Fasting blood suger. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Hb A1c. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.	—

Measure

Time frame

Fasting blood suger. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Hb A1c. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Lipid profile. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Visfatin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.;Insulin. Timepoint: At the beginning of the intervention and 60 days after the intervention began. Method of measurement: Measure with laboratory kit on blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadi Shourestani

Zahedan University of Medical Sciences

shadi.shourestani@gmail.com+98 56 3243 3865

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026